Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Multi-Institutional Trial Utilizes POETIC Consortium of Ten Institutions with First Patient Dosed at The Children's Hospital, Denver CO. NEW...
Multi-Institutional Trial Utilizes POETIC Consortium of Ten Institutions with First Clinical Sites Opened at the Phoenix Children's Hospital and...
NEW YORK, Feb. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; Frankfurt: CA4), a biopharmaceutical company focused on...
NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; News; FWB: CA4), a developer of new drug treatments in...
NEW YORK, Jan. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the...
NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; Frankfurt: CA4), a biopharmaceutical company primarily...
Paper Published in Oncogene Highlights Animal Model Data on Degrasyn Drug Candidate WP1066 NEW YORK, Jan. 23 /PRNewswire-FirstCall/ -- Callisto...
Independent German Based Equity Research Firm Maintains Buy Rating, Speculative Risk Rating and Projected Share Price Target of $2.00 NEW YORK...
NEW YORK, Dec. 28 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4) today announced that, effective January 1...
NEW YORK, Dec. 27 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the...
NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the...
Independent German Based Equity Research Firm Maintains Buy Rating NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc...
Research Agreement to Support Biological Studies on New Tumor-Fighting Class of Drugs NEW YORK, June 15 /PRNewswire-FirstCall/ -- Callisto...
Analyst Cites Recent Callisto Announcement of Encouraging Anti-Tumor Response of Drug Candidate Atiprimod NEW YORK, March 14...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지